0001293577-17-000002.txt : 20170831
0001293577-17-000002.hdr.sgml : 20170831
20170831185800
ACCESSION NUMBER: 0001293577-17-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170830
FILED AS OF DATE: 20170831
DATE AS OF CHANGE: 20170831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katz Richard D
CENTRAL INDEX KEY: 0001293577
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 171064230
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-08-30
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001293577
Katz Richard D
4505 EMPEROR BOULEVARD
SUITE 300
DURHAM
NC
27703
0
1
0
0
VP and Chief Financial Officer
Common Stock
2017-08-30
4
A
0
395664
0
A
399622
D
The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 197,832 shares on January 2, 2018, and with respect to the remaining 197,832 shares on January 9, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.
/s/ Lori R. Harrelson, attorney-in-fact
2017-08-31